Table 3.
Method | Analyte | Linear range | Concentration (μg/mL) | Recovery (%) | LOD | Reference |
---|---|---|---|---|---|---|
LLE–GC/MS | MA, PD, TD, etc. | 10–5000 ng/mL | 2.5 | 63.3–81.1 | 2 ng/mL | [18] |
SPE–GC/MS | MA, PD, TD, etc. | 10–5000 ng/mL | 2.5 | 66.8–98.5 | 2 ng/mL | [18] |
SPE–GC/MS | MA, KT, etc. | 5–200 ng/mL | 0.1 | 95.4–96.8 | 2.5 ng/mL | [19] |
SPE–GC/MS | MA, KT, TD, etc. | 0.2–50 μg/mL | 10 | 30–82 | 0.06–2 μg/mL | [20] |
LLE–GC/MS | MA, PD, TD, KT | – | 0.5 | 63–104 | 25–50 ng/mL | [21] |
SPE–GC/MS | PD | 1.25–40 ng/mL | 0.02 | 109 ± 10.9 | 0.5 ng/mL | [22] |
DLLME–GC/MS | MA, PD, TD, KT | 10–1000 ng/mL | 0.1 | 80.45–95.55 | 0.43–1.96 ng/mL | Present work |